Lucid Diagnostics (LUCD) Cash from Financing Activities (2020 - 2026)

Lucid Diagnostics has reported Cash from Financing Activities for 7 years, with the latest figure at $5.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 64.46% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at $49.1 million (up 8.67% YoY), and the FY2025 full-year result was $59.0 million, up 22.34% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $5.5 million, up from $2000.0 in the prior quarter.
• The five-year high for Cash from Financing Activities was $27.1 million in Q3 2025, with the low at $1000.0 in Q4 2022.
• Historically, Cash from Financing Activities has averaged $9.1 million across 5 years, with a median of $5.2 million in 2023.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities slumped 100.0% — and 2023, when it soared 499900.0%.
• Lucid Diagnostics' Cash from Financing Activities stood at $1000.0 in 2022, then soared by 499900.0% to $5.0 million in 2023, then jumped by 259.98% to $18.0 million in 2024, then tumbled by 99.99% to $2000.0 in 2025, then soared by 274250.0% to $5.5 million in 2026.
• The last three Cash from Financing Activities figures came in at $5.5 million (Q1 2026), $2000.0 (Q4 2025), and $27.1 million (Q3 2025), per Business Quant data.